For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s tossing a football with friends or navigating the Superdome steps during the b ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $1.43 million focused on non-addictive pain management treatments, has ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

that cause symptoms and can't be fully removed with surgery. Nearly a Quarter of Americans Endured Chronic Pain Last YearNew CDC data shows that in a survey, 24% of adults said they had pain most ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

The surgical procedures and assessments were ... Virpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug ...